News Summary

Samsung’s venture capital arm is reportedly planning to invest in Exo, a California-based medical imaging startup, in a funding round that could reach $100 million. This round is led by Sands Capital, Bold Capital, and Qubit Health Capital, with Qubit’s chairman, Imar Ishrak, expected to join Exo’s board. Exo specializes in handheld medical imaging devices that integrate AI and silicon technology, enabling medical examiners to perform ultrasound examinations via a smartphone app. This potential investment positions Samsung to enhance its presence in the medical imaging sector, potentially partnering with Samsung Medison for further technological advancements.